News Archive

FastForward, the catalyst for the advancement and commercialization of Johns Hopkins innovations, will help drive business development. There will be some available space outfitted as a core lab facility with shared equipment. Approximately 115,000 SF of the building is already committed. An additional 53,000 SF of lab and office space is available. Additionally, there will be 2,000 SF of retail space that will open directly to the lobby and serve as the social hub for innovation activities in the building. This space will have 180 degree exposure to Ashland Avenue and Eager Park. The retail tenant can extend its outdoor operation onto the ground floor building terrace and into Eager Park.

The stage has been set for a disruptive return of the “Small IPO” to the private equity marketplace (Seed, Series A, B etc.). This go-around, the liquidity boom will not be the exclusive provenance of the Four Horsemen (Alex Brown Inc., Hambrecht & Quist, Robertson Stephens & Co., and Montgomery Securities), the four boutique investment banks that drove liquidity for Silicon Valley during the boom. The new incarnation of the Four Horsemen will be in the form of crowdfunding marketplaces, not investment banks.

WASHINGTON DC—AARP today announced the launch of a new program to give developers of popular and emerging products insight into how Americans 50-plus use technology in order to identify ways to improve the devices for mature consumers. The initiative is called Project Catalyst and its first study is focused on popular activity and sleep trackers. In conjunction with UnitedHealthcare and Pfizer Inc., this is the first of several technology studies that AARP will conduct with the goal of accelerating innovation for aging Americans. “Technology that is designed well – designed for all – can be used by a 5-year-old and a 95-year-old, alike. We are thrilled about starting this study and commencing the launch of the Project Catalyst program, said Jody Holtzman, AARP senior vice president of Thought Leadership. “The goals of Project Catalyst are in direct alignment with the mission of AARP – to identify challenges and determine solutions to improve the quality of life for people as they age.”

Like plenty of science-oriented high school kids, Andrew Jin is interested in human evolution. But Jin, one of three $150,000 first-place winners in this year’s Intel Science Talent Search, took that interest further than most. For his project, the high school senior came up with machine learning algorithms that detect mutations in the human genome—mutations that could one day be used to develop drugs to combat diseases like HIV and schizophrenia.

Did you know you could use your iPhone to monitor your pulse and oxygen levels? From nanobot surgery to microchip medical records, new medical technologies come about in different ways. Check out the infographic below to see what affects medical research, research spending numbers, and some of the important technologies now available as a result:

WASHINGTON – U.S. Senator Barbara A. Mikulski (D-Md.), Vice Chairwoman of the Senate Appropriations Committee, this week continued her Maryland Jobs Tour at the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS). Senator Mikulski announced that she has introduced new legislation, the Accelerating Biomedical Research Act, to ensure NIH receives stable funding year after year to support community health, innovation and jobs across Maryland and the nation. Senator Mikulski was joined by NIH Director Dr. Francis S. Collins and NCATS Director Dr. Christopher P. Austin in touring the NCATS translational research facility to see first-hand state-of-the-art screening for potential new treatments and cures for diseases that can be delivered to patients faster.

When it comes to dividend income, there are few industries more sought after than pharmaceutical stocks. More specifically, investors tend to focus on the 10 largest companies by market cap in pharmaceuticals because they’re likely to have established product portfolios, deep drug development pipelines, and significant cash flow that allows them to pay dividends regularly higher than the S&P 500 average of 2%. In fact, of the 10 largest companies by market cap in pharmaceuticals, there isn’t one with a dividend yield lower than 2.2%, and the combined operating cash flow of these 10 companies over the trailing-12-month period equaled — get ready for this — $91.3 billion!

The decline in first quarter digital health investment was a notable shift from the steadily rising levels since 2010. That’s probably the most striking development in StartUp Health’s latest report which otherwise highlighted some pretty consistent trends. In the the first three months of 2015, big data attracted the most investment (led by Health Catalyst, which raised $70 million). Plus, more venture capitalists are moving into the sector – at least 20 made two digital health investments. But the second half of the report, which looks at digital health subsectors and deals relevant to the graying market – ie. almost every aspect of consumer health – was a promotional, business-intelligence look at what’s happening with the constituents of one of its sponsors, AARP. Reading the report, I wonder if it really provides enough firepower for innovators to help that 50+ population.

The Institute of Medicine has tapped Dr. Margaret Hamburg, former commissioner of the U.S. Food and Drug Administration, to serve as its next foreign secretary. Hamburg stepped down from the FDA last month after nearly six years at the agency, the longest term served since Dr. David Kessler, who served in the presidential administrations of both George H.W. Bush and Bill Clinton. Dr. Stephen Ostroff has been named acting commissioner at the FDA. In her new, part-time role as the IOM’s foreign secretary, Hamburg will serve as a senior adviser on international matters to the IOM president and council, as well as a liaison to other countries’ academies of medicine and science. A part of the National Academy of Sciences, the Institute provides independent advice to policymakers, health professionals, businesses and the public.

U.S. Secretary of Commerce Penny Pritzker announced the first 26 recipients of the 2014 Regional Innovation Strategies program grants. Managed by the Economic Development Administration, the Regional Innovation Strategies (RIS) program is designed to advance innovation and capacity-building activities in regions across the country through three different types of grants.